CVS Health Corp
CVS79.420USD
-1.380-1.71%
Handelsschluss 12/12, 16:00（ET）Kurse um 15 Minuten verzögert
100.86BMarktkapitalisierung
211.34KGV TTM
mehr Informationen über CVS Health Corp Unternehmen
CVS Health Corporation is a health solutions company. The Company's segments include Health Care Benefits, Health Services, Pharmacy & Consumer Wellness and Corporate/Other. The Health Care Benefits segment offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, PDPs and Medicaid health care management services. The Health Services segment provides a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home, and offers provider enablement solutions. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, diagnostic testing and vaccination administration, and sells an assortment of health and wellness products and general merchandise.
CVS Health Corp Informationen
BörsenkürzelCVS
Name des UnternehmensCVS Health Corp
IPO-datumNov 06, 2088
CEOJoyner (J. David David)
Anzahl der mitarbeiter300000
WertpapierartOrdinary Share
GeschäftsjahresendeNov 06
AddresseOne Cvs Dr.
StadtWOONSOCKET
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited States of America
Postleitzahl02895
Telefon14017651500
Websitehttps://cvshealth.com/
BörsenkürzelCVS
IPO-datumNov 06, 2088
CEOJoyner (J. David David)
Führungskräfte von CVS Health Corp
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Larry Robbins
Mr. Larry Robbins
Independent Director
Independent Director
11.95M
--
Mr. Michael F. (Mike) Mahoney
Mr. Michael F. (Mike) Mahoney
Lead Independent Director
Lead Independent Director
45.91K
+0.31%
Mr. Tilak Mandadi
Mr. Tilak Mandadi
Executive Vice President, Chief Data, Digital, Analytics and Technology Officer
Executive Vice President, Chief Data, Digital, Analytics and Technology Officer
40.60K
-13.94%
Mr. Steven H. Nelson
Mr. Steven H. Nelson
Executive Vice President and President - Aetna
Executive Vice President and President - Aetna
21.33K
--
Mr. Guy P. Sansone
Mr. Guy P. Sansone
Independent Director
Independent Director
13.66K
+13.76%
Mr. Douglas H. (Doug) Shulman, J.D.
Mr. Douglas H. (Doug) Shulman, J.D.
Independent Director
Independent Director
5.93K
+38.63%
Ms. Leslie V. Norwalk
Ms. Leslie V. Norwalk
Director
Director
5.93K
+38.63%
Mr. Roger N. Farah
Mr. Roger N. Farah
Director
Director
4.12K
-92.40%
Ms. Alecia A. Decoudreaux, J.D.
Ms. Alecia A. Decoudreaux, J.D.
Independent Director
Independent Director
2.97K
--
Dr. Amy L. Compton-Phillips, M.D.
Dr. Amy L. Compton-Phillips, M.D.
Executive Vice President and Chief Medical Officer
Executive Vice President and Chief Medical Officer
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Larry Robbins
Mr. Larry Robbins
Independent Director
Independent Director
11.95M
--
Mr. Michael F. (Mike) Mahoney
Mr. Michael F. (Mike) Mahoney
Lead Independent Director
Lead Independent Director
45.91K
+0.31%
Mr. Tilak Mandadi
Mr. Tilak Mandadi
Executive Vice President, Chief Data, Digital, Analytics and Technology Officer
Executive Vice President, Chief Data, Digital, Analytics and Technology Officer
40.60K
-13.94%
Mr. Steven H. Nelson
Mr. Steven H. Nelson
Executive Vice President and President - Aetna
Executive Vice President and President - Aetna
21.33K
--
Mr. Guy P. Sansone
Mr. Guy P. Sansone
Independent Director
Independent Director
13.66K
+13.76%
Mr. Douglas H. (Doug) Shulman, J.D.
Mr. Douglas H. (Doug) Shulman, J.D.
Independent Director
Independent Director
5.93K
+38.63%
Umsatzaufteilung
Währung: USDAktualisiert: Mon, Oct 6
Währung: USDAktualisiert: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Pharmacy
55.35B
55.96%
Premiums
34.20B
34.57%
Front Store
5.37B
5.43%
Other
3.52B
3.55%
Net investment income(loss)
487.00M
0.49%
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Pharmacy
55.35B
55.96%
Premiums
34.20B
34.57%
Front Store
5.37B
5.43%
Other
3.52B
3.55%
Net investment income(loss)
487.00M
0.49%
Aktionärsstatistik
Aktualisiert: Sat, Nov 15
Aktualisiert: Sat, Nov 15
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
9.31%
Dodge & Cox
5.76%
Capital World Investors
5.39%
BlackRock Institutional Trust Company, N.A.
5.07%
State Street Investment Management (US)
4.64%
Andere
69.82%
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
9.31%
Dodge & Cox
5.76%
Capital World Investors
5.39%
BlackRock Institutional Trust Company, N.A.
5.07%
State Street Investment Management (US)
4.64%
Andere
69.82%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
46.50%
Investment Advisor/Hedge Fund
31.43%
Hedge Fund
3.09%
Research Firm
2.77%
Pension Fund
2.16%
Bank and Trust
1.96%
Sovereign Wealth Fund
1.65%
Individual Investor
1.06%
Insurance Company
0.10%
Andere
9.27%
Institutionelle Beteiligung
Aktualisiert: Mon, Dec 8
Aktualisiert: Mon, Dec 8
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
3559
1.14B
91.37%
+184.05K
2025Q3
3681
1.14B
91.69%
+21.03M
2025Q2
3720
1.12B
91.24%
+11.94M
2025Q1
3762
1.11B
87.65%
+493.45K
2024Q4
3844
1.07B
85.40%
+28.70M
2024Q3
3797
1.04B
85.89%
-7.86M
2024Q2
3821
1.05B
84.06%
+19.75M
2024Q1
3841
1.03B
84.50%
-33.86M
2023Q4
3855
1.05B
81.50%
+16.24M
2023Q3
3736
1.03B
81.41%
+4.51M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
The Vanguard Group, Inc.
119.78M
9.44%
+2.04M
+1.74%
Jun 30, 2025
Dodge & Cox
73.29M
5.78%
-170.36K
-0.23%
Jun 30, 2025
Capital World Investors
66.96M
5.28%
-1.44M
-2.10%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
63.56M
5.01%
-1.40M
-2.15%
Jun 30, 2025
State Street Investment Management (US)
58.79M
4.64%
+800.41K
+1.38%
Jun 30, 2025
Fidelity Management & Research Company LLC
37.59M
2.96%
+13.37M
+55.22%
Jun 30, 2025
Geode Capital Management, L.L.C.
28.64M
2.26%
+675.82K
+2.42%
Jun 30, 2025
Capital International Investors
26.39M
2.08%
+202.05K
+0.77%
Jun 30, 2025
Norges Bank Investment Management (NBIM)
19.70M
1.55%
+994.06K
+5.31%
Jun 30, 2025
BlackRock Investment Management, LLC
16.04M
1.26%
+10.29M
+178.77%
Jun 30, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
iShares U.S. Healthcare Providers ETF
12.05%
Invesco S&P Ultra Dividend Revenue ETF
6.26%
Coastal Compass 100 ETF
5.67%
Davis Select US Equity ETF
5.6%
Simplify Health Care ETF
5.48%
VanEck Retail ETF
4.53%
iShares US Consumer Staples ETF
4.18%
Invesco S&P 500 Pure Value ETF
3.71%
Invesco S&P 500 Enhanced Value ETF
3.03%
JPMorgan Healthcare Leaders ETF
2.99%
Mehr Anzeigen
iShares U.S. Healthcare Providers ETF
Anteil12.05%
Invesco S&P Ultra Dividend Revenue ETF
Anteil6.26%
Coastal Compass 100 ETF
Anteil5.67%
Davis Select US Equity ETF
Anteil5.6%
Simplify Health Care ETF
Anteil5.48%
VanEck Retail ETF
Anteil4.53%
iShares US Consumer Staples ETF
Anteil4.18%
Invesco S&P 500 Pure Value ETF
Anteil3.71%
Invesco S&P 500 Enhanced Value ETF
Anteil3.03%
JPMorgan Healthcare Leaders ETF
Anteil2.99%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
14.66B
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Sep 17, 2025
CVS.NB Interim Cash Dividend of gross USD 0.665 paid on Nov 03, 2025 going ex on Oct 23, 2025
Oct 23, 2025
Nov 03, 2025
Oct 23, 2025
Jul 07, 2025
CVS.NB Interim Cash Dividend of gross USD 0.665 paid on Aug 01, 2025 going ex on Jul 22, 2025
Jul 22, 2025
Aug 01, 2025
Jul 22, 2025
Mar 20, 2025
CVS.NB Interim Cash Dividend of gross USD 0.665 paid on May 01, 2025 going ex on Apr 22, 2025
Apr 22, 2025
May 01, 2025
Apr 22, 2025
Jan 03, 2025
CVS.NB Interim Cash Dividend of gross USD 0.665 paid on Feb 03, 2025 going ex on Jan 23, 2025
Jan 23, 2025
Feb 03, 2025
Jan 23, 2025
Sep 19, 2024
CVS.NB Interim Cash Dividend of gross USD 0.665 paid on Nov 01, 2024 going ex on Oct 21, 2024
Oct 21, 2024
Nov 01, 2024
Oct 21, 2024
Jul 08, 2024
CVS.NB Interim Cash Dividend of gross USD 0.665 paid on Aug 01, 2024 going ex on Jul 22, 2024
Jul 22, 2024
Aug 01, 2024
Jul 22, 2024
Mar 21, 2024
CVS.NB Interim Cash Dividend of gross USD 0.665 paid on May 01, 2024 going ex on Apr 19, 2024
Apr 22, 2024
May 01, 2024
Apr 19, 2024
Dec 06, 2023
CVS.NB Final Cash Dividend of gross USD 0.665 paid on Feb 01, 2024 going ex on Jan 19, 2024
Jan 22, 2024
Feb 01, 2024
Jan 19, 2024
Sep 21, 2023
CVS.NB Interim Cash Dividend of gross USD 0.605 paid on Nov 01, 2023 going ex on Oct 19, 2023
Oct 20, 2023
Nov 01, 2023
Oct 19, 2023
Jul 07, 2023
CVS.NB Interim Cash Dividend of gross USD 0.605 paid on Aug 01, 2023 going ex on Jul 20, 2023
Jul 21, 2023
Aug 01, 2023
Jul 20, 2023
Mehr Anzeigen
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von CVS Health Corp?
Die fünf größten Anteilseigner von CVS Health Corp sind:
The Vanguard Group, Inc. hält 119.78M Aktien, was 9.44% der Gesamtaktien entspricht.
Dodge & Cox hält 73.29M Aktien, was 5.78% der Gesamtaktien entspricht.
Capital World Investors hält 66.96M Aktien, was 5.28% der Gesamtaktien entspricht.
BlackRock Institutional Trust Company, N.A. hält 63.56M Aktien, was 5.01% der Gesamtaktien entspricht.
State Street Investment Management (US) hält 58.79M Aktien, was 4.64% der Gesamtaktien entspricht.
The Vanguard Group, Inc. hält 119.78M Aktien, was 9.44% der Gesamtaktien entspricht.
Dodge & Cox hält 73.29M Aktien, was 5.78% der Gesamtaktien entspricht.
Capital World Investors hält 66.96M Aktien, was 5.28% der Gesamtaktien entspricht.
BlackRock Institutional Trust Company, N.A. hält 63.56M Aktien, was 5.01% der Gesamtaktien entspricht.
State Street Investment Management (US) hält 58.79M Aktien, was 4.64% der Gesamtaktien entspricht.
Was sind die drei wichtigsten Anteilseigner-Typen von CVS Health Corp?
Die drei wichtigsten Anteilseigner-Typen von CVS Health Corp sind:
The Vanguard Group, Inc.
Dodge & Cox
Capital World Investors
The Vanguard Group, Inc.
Dodge & Cox
Capital World Investors
Wie viele Institutionen halten Anteile an CVS Health Corp (CVS)?
Mit Stand vom 2025Q4 halten 3559 Institutionen Anteile an CVS Health Corp, mit einem Gesamtmarktwert von etwa 1.14B, was 91.37% der Gesamtanteile entspricht. Im Vergleich zum 2025Q3 ist der institutionelle Aktienbesitz um -0.32% gestiegen.
Was ist die größte Einnahmequelle von CVS Health Corp?
Am FY2025Q2 erzielte das Geschäft mit Pharmacy für CVS Health Corp den höchsten Umsatz in Höhe von 55.35B, was 55.96% des Gesamtumsatzes entspricht.
